DWTX
NASDAQ · Biotechnology
Dogwood Therapeutics Inc
$3.17
+0.00 (+0.00%)
Open$3.14
Previous Close$3.17
Day High$3.17
Day Low$3.05
52W High$25.53
52W Low$10.98
Volume—
Avg Volume638.7K
Market Cap101.70M
P/E Ratio34.30
EPS$0.50
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+596.5% upside
Current
$3.17
$3.17
Target
$22.08
$22.08
$13.69
$22.08 avg
$22.84
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 12.10M | 11.96M | 10.98M |
| Net Income | 3.15M | 2.42M | 2.50M |
| Profit Margin | 26.0% | 20.2% | 22.8% |
| EBITDA | 4.53M | 4.37M | 3.74M |
| Free Cash Flow | 1.56M | 1.43M | 1.67M |
| Rev Growth | +0.7% | +19.7% | +24.9% |
| Debt/Equity | 0.93 | 0.73 | 0.93 |
Dividend
Dividend Yield1.09%
Annual Dividend$0.19
Payout Ratio37.5%
Frequencyquarterly
Ex-DividendMar 9, 2026
Pay DateMar 23, 2026
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |